A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer

Jennifer M. Segar, Darien Reed, Alison Stopeck, Robert B. Livingston, Pavani Chalasani

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases